ELI LILLY & Co — Director's Dealing 2013

Mar 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2009-12-01

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-12-01	Restricted Stock Unit	$	A	4584	Acquired	2016-12-01	CommonStock (4584)	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.